Tel: +44(0)20 7691 0984 Email: contact@transpharmation.co.uk Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...
 

Our Team

Meet the team! This is our senior management and scientific team. They are supported by twenty other members at various sites. We're involved in many different projects in the UK and across the globe, dedicating the right level of experience and expertise to every client project.

Mark Duxon PhD

linkedin


Every day brings us closer to discovering a major breakthrough in the search for new drugs to prevent, alleviate or cure. Mark is passionate about translational biology and the pivotal role it has towards delivering this.

As CEO of well known CRO companies in France and Singapore, he has enjoyed a privileged position in leading and influencing vital drug discovery programmes. Here in the UK, as CEO of Transpharmation, Mark’s work continues in translational biology with innovative science at the core.


markOutside of work Mark’s interests are rooted in the countryside with dogs, tractors and a farmyard thrown into the mix.

 

Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120

mail contact@transpharmation.co.uk


Copyright

Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design